Intellia Therapeutics, Inc. NTLA
Price alert —
Sign in to get a one-time email the moment NTLA crosses your price. Free accounts included.
Sign in / create a free accountIntellia Therapeutics, Inc. is a healthcare company listed in the US.
NTLA last traded at $11.11, down 3.1% on the day; that's in the lower part of its 52-week range ($10.91–$18.48). Right now it's stretched well below its recent average — historically the kind of washed-out level where bounces tend to start.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and after the recent dip, watch whether the price stops making lower lows before assuming the worst is over.
A quick snapshot built from the data on this page — not investment advice. Always do your own research.
On the latest daily bar, momentum sits mid-range (RSI 32), the trend is strong (ADX 30), and trading is light at 0.3× normal volume. On the business side, revenue is shrinking 10% year over year and the business keeps about -348 cents of every sales dollar as free cash.
Latest-bar indicator readings behind the grade — display-only, they don't move the letter.
Company fundamentals for context — display-only, they don't move the grade.
The model's verdict is “Unknown” and accounting quality screens as Weak. Model estimates only — do your own due diligence.
- ✓ More cash than debt
- ✓ Quick ratio 3.71 (antifragile)
- ✓ Current ratio 5.08 (antifragile)
- ✓ Debt/equity 0.25 (antifragile)
- ⚠ Negative retained earnings
- ⚠ Stock comp 119% of revenue (heavy dilution)
NTLA is a $1.6 billion company, the stock is trading near the bottom of its 52-week range.